Hongwei Jin

The paper discovers a new class of DNA gyrase inhibitors, 1,4-dicarbonylthiosemicarbazides, with potent activity against MRSA through design, synthesis, and biological evaluation.

This paper identifies a novel DYRK1A inhibitor, compound Q17, through computational screening and validates its efficacy in reducing AD-related pathology in vitro and in vivo.